OpenURL Connection Search

Select item for more details and to access through your institution.

Change in Serum Lipids after Acute Coronary Syndromes: Secondary Analysis of SPACE ROCKET Study Data and a Comparative Literature Review.
Published in:
Clinical Chemistry, 2010, v. 56, n. 10, p. 1592
By:
- Barth, Julian H.;
- Jackson, Beryl M.;
- Farrin, Amanda J.;
- Efthymiou, Maria;
- Worthy, Gillian;
- Copeland, Joanne;
- Bailey, Kristian M.;
- Romaine, Simon P.R.;
- Balmforth, Anthony J.;
- McCormack, Terry;
- Whitehead, Andrew;
- Flather, Marcus D.;
- Nixon, Jane;
- Hall, Alistair S.
Publication type:
Article
Systematic Review and Network Meta-Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia.
Published in:
2017
By:
- Toth, Peter P.;
- Worthy, Gillian;
- Gandra, Shravanthi R.;
- Sattar, Naveed;
- Bray, Sarah;
- Cheng, Lung‐I.;
- Bridges, Ian;
- Worth, Gavin M.;
- Dent, Ricardo;
- Forbes, Carol A.;
- Deshpande, Sohan;
- Ross, Janine;
- Kleijnen, Jos;
- Stroes, Erik S. G.
Publication type:
journal article
Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Published in:
2021
By:
- Witlox, Willem J. A.;
- Grimm, Sabine E.;
- Riemsma, Rob;
- Armstrong, Nigel;
- Ryder, Steve;
- Duffy, Steven;
- Carrera, Vanesa Huertas;
- Posadzki, Pawel;
- Worthy, Gillian;
- Pouwels, Xavier G. L. V.;
- Ramaekers, Bram L. T.;
- Kleijnen, Jos;
- Joore, Manuela A.;
- van Asselt, Antoinette D. I.
Publication type:
journal article
Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Published in:
2019
By:
- Grimm, Sabine E.;
- Fayter, Debra;
- Ramaekers, Bram L. T.;
- Petersohn, Svenja;
- Riemsma, Rob;
- Armstrong, Nigel;
- Pouwels, Xavier;
- Witlox, Willem;
- Noake, Caro;
- Worthy, Gillian;
- Kleijnen, Jos;
- Joore, Manuela A.
Publication type:
journal article
Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Published in:
2019
By:
- Grimm, Sabine E.;
- Ramaekers, Bram L. T.;
- Pouwels, Xavier;
- Petersohn, Svenja;
- Joore, Manuela A.;
- Armstrong, Nigel;
- Lang, Shona;
- Riemsma, Rob;
- Worthy, Gillian;
- Stirk, Lisa;
- Ross, Janine;
- Kleijnen, Jos
Publication type:
journal article

Found: 5

Change in Serum Lipids after Acute Coronary Syndromes: Secondary Analysis of SPACE ROCKET Study Data and a Comparative Literature Review.

Systematic Review and Network Meta-Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia.

Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.